Analystreport

Sucampo Pharmaceuticals, Inc. (NASDAQ: SCMP) was given a new $30.00 price target on by analysts at Roth Capital. They now have a "buy" rating on the stock.

SUCAMPO PHARMACEUTICALS  (SCMP) 
Last sucampo pharmaceuticals earnings: 11/1 06:30 am Check Earnings Report
US:NASDAQ Investor Relations: ir.sucampo.com